News

FGI Industries Reports Significant Growth in Q3 2024 Results

FGI Industries Reports Significant Growth in Q3 2024 Results

FGI Industries Announces Third Quarter 2024 Results

FGI Industries Ltd. (NASDAQ: FGI), a prominent global supplier in kitchen and bath products, has announced its results for the latest quarter, showcasing impressive financial performance and ongoing growth strategies.

Third Quarter Highlights

In the third quarter of 2024, FGI Industries reported total revenue of $36.1 million, marking a remarkable year-over-year increase of 20.6%. The gross profit reached an impressive $9.3 million, with a gross margin of 25.8%, although it experienced a slight decrease compared to the previous year. Operating losses were recorded at $0.1 million, and the net loss attributable to shareholders was $0.6 million. The adjusted operating income stood at $0.1 million.

Management Perspective

“We are thrilled to see our revenue increase this quarter significantly,” said Dave Bruce, President and CEO of FGI. This growth was driven by healthy demand across all our markets, notably with a 39% rise in our European segment, 9% in Canada, and 21% in the U.S. Our product categories, especially Sanitaryware and Bath Furniture, also noted substantial recovery and growth during this period. Our Covered Bridge cabinet segment has shown remarkable potential, demonstrating a notable growth of 93% over the past year,” Bruce continued.

Perry Lin, CFO, added, “While we’ve seen a 20.6% increase in revenue, we also need to acknowledge that our operational expenses rose by 27.6%, primarily due to strategic investments in our kitchen cabinet business and distribution in Canada. Despite the increase in expenses, our liquidity remains strong, closing the quarter with $16.3 million in total liquidity. Our focus continues to be on maximizing our investments for sustained internal growth.”

Segment Performance Overview

FGI’s revenue by segment for Q3 2024 is as follows:

  • Sanitaryware revenue: $21.5 million, up from $20.7 million the previous year.
  • Bath Furniture revenue: $4.2 million, significantly increasing from $2.5 million.
  • Shower Systems revenue: $7.1 million, rising from $4.9 million in the prior year.
  • Other revenue including Kitchen Cabinets: $3.3 million, up from $1.7 million previously.

The overall gross profit for the quarter amounted to $9.3 million, illustrating an 18.9% growth from prior year periods, despite a 40 basis point drop in the gross margin.

Evaluating Financial Resources and Guidance

As of September 30, 2024, FGI Industries reported total current liabilities of $39.7 million and total liquidity of $16.3 million. The updated 2024 financial guidance predicts a total revenue between $127 and $131 million, showing a positive adjustment from earlier estimates. However, adjusted operating income is projected to be between –$1.0 million and $0.0 million.

Conference Call Information

FGI will hold a conference call to discuss these results, scheduled to take place soon. Shareholders and interested parties are encouraged to participate for insights on FGI's growth trajectory and strategy moving forward.

About FGI Industries

FGI Industries Ltd. (NASDAQ: FGI) has established itself as a leading supplier in the kitchen and bath industry, specializing in a diverse range of product categories, including sanitaryware, bath furniture, and custom cabinetry. For over thirty years, FGI has been recognized for its commitment to product quality and innovation, catering primarily to the repair and remodeling sector.

Frequently Asked Questions

What are the significant financial highlights of FGI Industries in Q3 2024?

FGI Industries reported a revenue increase of 20.6% to $36.1 million and a gross profit of $9.3 million, reflecting continued growth across its business segments.

How did FGI Industries perform in different regional markets?

In Q3 2024, revenue grew by 39% in Europe, 9% in Canada, and 21% in the U.S., showcasing strong geographical diversification and demand.

What challenges is FGI facing with its operational expenses?

While revenue saw substantial growth, operational expenses increased by 27.6%, mainly due to investments in the kitchen cabinet business and distribution logistics.

How is FGI managing its liquidity and financial resources?

FGI reported total liquidity of $16.3 million at the end of Q3 2024, ensuring sufficient working capital to support its operations and strategic initiatives.

What is the outlook for FGI Industries in subsequent quarters?

FGI has revised its fiscal 2024 guidance upwards, projecting total revenue between $127 and $131 million while also addressing potential challenges in achieving positive adjusted operating income.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 19

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 24

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 30

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 18

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 25

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Alterity Therapeutics Showcases Innovation at Healthcare Event

Updated Category News Views 142

Alterity Therapeutics to Present at a Virtual Healthcare Conference Alterity Therapeutics, a biotechnology firm dedicated to developing treatments for neurodegenerative diseases, has recently announced its participation in an upcoming healthcare virtual conference. The event will shine a spotlight on influential healthcare companies and their innovative approaches to...

Continue Reading
Important Update for Toronto-Dominion Bank Investors on Lawsuit

Updated Category News Views 58

Update for Investors in Toronto-Dominion Bank Kahn Swick & Foti, LLC, led by the experienced former Louisiana Attorney General Charles C. Foti, Jr., is reminding investors that significant changes are arriving for shareholders of Toronto-Dominion Bank (NYSE: TD). As the legal landscape evolves, those who experienced losses may want to take immediate action regarding their...

Continue Reading
GCC's Quarterly Performance Analysis: Key Insights Revealed

Updated Category News Views 221

GCC Reports Significant First Quarter Financials GCC, S.A.B. de C.V. (BMV: GCC*), recognized as a premier supplier and producer of cement, concrete, and aggregates, has shared its financial results for the first quarter. Despite facing various challenges, GCC's performance metrics reveal a resilience that is noteworthy. Q1 2025 Highlights In the first quarter of 2025, GCC...

Continue Reading
Indonesia's IDX Composite Index Declines Amid Market Pressures

Updated Category News Views 116

Overview of Recent Market Movements in Indonesia Indonesia's stock market experienced a downturn at the close of trading, influenced by various sectors showing significant losses. The IDX Composite Index reflected a decrease of 0.98%, marking a notable dip to a one-month low. This downturn is primarily attributed to declines in several key sectors, including...

Continue Reading
Blink Charging Achieves Advanced Certification for EV Chargers

Updated Category News Views 130

Blink Charging Receives Prestigious OCPP 2.0.1 Certification Blink stands out as one of just five EV charging companies in the U.S. to earn this coveted certification. Bowie, Md. – Blink Charging Co. (NASDAQ: BLNK), a prominent name in electric vehicle (EV) charging equipment and services, has proudly announced that its Series 7, 8, and 9 charger models have...

Continue Reading